pharmacokinetics

Results: 1088



#Item
951Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations  U.S. Department of Health and Human Services

Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations U.S. Department of Health and Human Services

Add to Reading List

Source URL: www.fda.gov

Language: English
952Guideline for Industry Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies

Guideline for Industry Pharmacokinetics: Guidance for Repeated Dose Tissue Distribution Studies

Add to Reading List

Source URL: www.fda.gov

Language: English
95319851se5-028 BPCA Lotensin Review

19851se5-028 BPCA Lotensin Review

Add to Reading List

Source URL: www.fda.gov

Language: English
954

PDF Document

Add to Reading List

Source URL: www.atsdr.cdc.gov

Language: English - Date: 2012-04-18 09:28:44
955Microsoft Word - 1923dft.doc

Microsoft Word - 1923dft.doc

Add to Reading List

Source URL: www.fda.gov

Language: English
956Guidance for Industry Dissolution Testing of Immediate Release Solid Oral Dosage Forms U.S. Department of Health and Human Services Food and Drug Administration

Guidance for Industry Dissolution Testing of Immediate Release Solid Oral Dosage Forms U.S. Department of Health and Human Services Food and Drug Administration

Add to Reading List

Source URL: www.fda.gov

Language: English
957Guidance for Industry #35 - Bioequivalence Guidance, revised November, 8, 2006

Guidance for Industry #35 - Bioequivalence Guidance, revised November, 8, 2006

Add to Reading List

Source URL: www.fda.gov

Language: English
958CLINICAL PHARMACOLOGY BLA REVIEW

CLINICAL PHARMACOLOGY BLA REVIEW

Add to Reading List

Source URL: www.fda.gov

Language: English
959Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations DRAFT GUIDANCE

Guidance for Industry Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations DRAFT GUIDANCE

Add to Reading List

Source URL: www.fda.gov

Language: English
960Microsoft Word[removed]5rev.DOC

Microsoft Word[removed]5rev.DOC

Add to Reading List

Source URL: www.fda.gov

Language: English